← Leaderboards
Wenliang Li
University Of Texas Hlth Sci Ctr Houston
$1,396,513
Attributed
$1,396,513
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $356.9K · FY2022–25$500K$375K$250K$125K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$1,396,513 · 1
By mechanism
R01$1,396,513 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Hlth Sci Ctr Houston
Same institution · by research overlap
- Luzhe Sun$18,197,911
- Dung-Fang Lee$2,986,751
- Vittorio Cristini$4,662,941
- Ashish A. Deshmukh$5,593,211
- Jan Bressler$488,791
Others in their field
Other Rising Stars on “Fitness”
- Xuping Xie · University Of Texas Med Br Galveston$14,015,062
- Nancy Glenn · Boise State University$8,000,000
- Dawn Fallacara · Battelle Centers/Pub Hlth Res & Evaluatn$4,929,913
- Amy Montague Sitapati · University Of California, San Diego$4,000,000
- Julien Papillon · University Of Texas Med Br Galveston$3,556,177
- Logan Grosenick · Weill Medical Coll Of Cornell Univ$3,339,048
Research focus
FitnessGenesAdrbk1 GeneExperimental StudyAdvanced Prostate CancerGene FunctionAutomobile DrivingAffectEventCancer CellCancer EtiologyCancer PatientCancer SubtypesCancer TypeCell LineCell ModelCellsCessation Of LifeBiologyAllelesEffective TherapyEnhancersEpigenetic ProcessGenetic
Grant awards (4)
Dissecting and targeting a novel vulnerability in aggressive Rb1 and p53 doubly deficient prostate cancer$356,850
R01 · FY2025 · CA · contact PI
Dissecting and targeting a novel vulnerability in aggressive Rb1 and p53 doubly deficient prostate cancer$339,008
R01 · FY2024 · CA · contact PI
Dissecting and targeting a novel vulnerability in aggressive Rb1 and p53 doubly deficient prostate cancer$346,789
R01 · FY2023 · CA · contact PI
Dissecting and targeting a novel vulnerability in aggressive Rb1 and p53 doubly deficient prostate cancer$353,866
R01 · FY2022 · CA · contact PI